id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2023-10-29 12:28:34
expired found date
-
created at
2024-06-08 22:53:32
updated at
2026-01-01 19:53:22
length
12
crc
40139
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
96773
mp size raw text
1460
mp inner links count
3
mp inner links status
20 (imported)
title
Vividion Therapeutics | Precision Therapeutics for Undruggable Targets
description
Biopharmaceutical unlocking traditionally undruggable targets with precision small molecule therapeutics. Learn more about our precision science inspired by human biology.
site name
Vividion Therapeutics
author
updated
2025-12-21 02:01:38
raw text
Vividion Therapeutics | Precision Therapeutics for Undruggable Targets Skip to main content Home Our Pipeline Our Platform Our People News Join Us Precision science inspired by human biology. Vividion Therapeutics is removing the boundaries of druggability to develop therapies for patients with critical unmet needs across multiple therapeutic areas. Uncover Our Platform A unified team with a singular mission. We are committed to delivering solutions for patients who may have once thought there was no treatment option for their disease. Meet Our Full Team We are reimagining the “impossible” to deliver possibility for all by combining decades of research with unprecedented know-how. We envision a future where there are treatments for all patients, no matter how difficult their disease is to target. See Our Pipeline Publications 09/07/2023 article Vividion Therapeutics Names Shawn Rose as Chief Develo...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025110801
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
1046
text words
194
text unique words
123
text lines
35
text sentences
9
text paragraphs
2
text words per sentence
21
text matched phrases
9
text matched dictionaries
2
links self subdomains
0
links other subdomains
links other domains
0
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
0
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-21 02:01:38
rss path
rss status
32 (unknown)
rss found date
2024-01-02 05:15:21
rss size orig
605
rss items
0
rss spam phrases
0
rss detected language
126 (language undetectable (empty document, too short, or engines disagree))
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)
sitemap review version
1
sitemap urls count
56
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2023-12-27 12:51:33
sitemap process date
2024-10-03 03:51:05
sitemap first import date
-
sitemap last import date
-